These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9359490

  • 1. Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells.
    Williams BA, Makrigiannis AP, Blay J, Hoskin DW.
    Int J Cancer; 1997 Nov 04; 73(3):416-23. PubMed ID: 9359490
    [Abstract] [Full Text] [Related]

  • 2. Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody.
    Zhao C, Morgan M, Haeryfar SM, Blay J, Hoskin DW.
    Cancer Immunol Immunother; 2003 Mar 04; 52(3):185-93. PubMed ID: 12649748
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE, Mahtabifard A, Yamada RE, Crystal RG, Korst RJ.
    J Thorac Cardiovasc Surg; 2003 Nov 04; 126(5):1609-17. PubMed ID: 14666041
    [Abstract] [Full Text] [Related]

  • 4. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.
    Clin Cancer Res; 1997 Jun 04; 3(6):963-72. PubMed ID: 9815772
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E, Baral E, Kangas L, Berczi I.
    Anticancer Res; 1997 Jun 04; 17(2A):1083-8. PubMed ID: 9137453
    [Abstract] [Full Text] [Related]

  • 11. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
    Frost P, Ng CP, Belldegrun A, Bonavida B.
    Cell Immunol; 1997 Aug 25; 180(1):70-83. PubMed ID: 9316641
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD3 antibody-induced activated killer cells subsets of killer cells that mediate fast or slow lytic reactions.
    Ting CC, Hargrove ME, Henrich P.
    Immunol Invest; 1990 Aug 25; 19(4):347-61. PubMed ID: 2145218
    [Abstract] [Full Text] [Related]

  • 13. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.
    Lee RK, Spielman J, Podack ER.
    Int Immunol; 1996 Jul 25; 8(7):991-1000. PubMed ID: 8757944
    [Abstract] [Full Text] [Related]

  • 14. Regulation by glutathione of the effect of lymphokines on differentiation of primary activated lymphocytes. Influence of glutathione on cytotoxic activity of CD3-AK-.
    Liang SM, Liang CM, Hargrove ME, Ting CC.
    J Immunol; 1991 Mar 15; 146(6):1909-13. PubMed ID: 1826013
    [Abstract] [Full Text] [Related]

  • 15. Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.
    Hoskin DW, Phu T, Makrigiannis AP.
    Int J Immunopharmacol; 1996 Nov 15; 18(11):623-31. PubMed ID: 9089006
    [Abstract] [Full Text] [Related]

  • 16. Combination immunotherapy of the P815 murine mastocytoma with killer cells, IL-2 and anti-estrogens.
    Baral E, Nagy E, Kangas L, Berczi I.
    Anticancer Res; 1997 Nov 15; 17(5A):3653-8. PubMed ID: 9413218
    [Abstract] [Full Text] [Related]

  • 17. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS, Hargrove ME, Ting CC.
    Cancer Res; 1989 Sep 01; 49(17):4770-4. PubMed ID: 2527087
    [Abstract] [Full Text] [Related]

  • 18. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
    Fitzpatrick L, Makrigiannis AP, Kaiser M, Hoskin DW.
    J Interferon Cytokine Res; 1996 Jul 01; 16(7):537-46. PubMed ID: 8836920
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ, Belldegrun A, Bonavida B.
    Prostate; 1999 Sep 15; 41(1):20-30. PubMed ID: 10440872
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway.
    Stewart JH, Nguyen DM, Chen GA, Schrump DS.
    J Thorac Cardiovasc Surg; 2002 Feb 15; 123(2):295-302. PubMed ID: 11828289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.